Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 600-401-889 - Provider product page
- Provider
- Rockland Immunochemicals, Inc.
- Proper citation
- Rockland Cat#600-401-889, RRID:AB_2228531
- Product name
- Anti-cbl-c (RABBIT) Antibody - 600-401-889
- Antibody type
- Polyclonal
- Vial size
- 100 µl
Submitted references Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma.
Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma.
Hong SY, Lu YC, Hsiao SH, Kao YR, Lee MH, Lin YP, Wang CY, Wu CW
Oncogene 2022 Mar;41(13):1907-1917
Oncogene 2022 Mar;41(13):1907-1917
Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma.
Hong SY, Kao YR, Lee TC, Wu CW
Cancer research 2018 Sep 1;78(17):4984-4996
Cancer research 2018 Sep 1;78(17):4984-4996
No comments: Submit comment
Supportive validation
- Submitted by
- Rockland Immunochemicals, Inc. (provider)
- Main image
- Experimental details
- Rockland's affinity purified anti-Cbl-c antibody was used at 5 ?g/ml to detect signal in a variety of tissues including multi-human, multi-brain and multi-cancer slides. This image shows moderate intracellular positive staining of human pancreatic acinar epithelium at 40X. Tissue was formalin-fixed and paraffin embedded. The image shows localization of the antibody as the precipitated red signal, with a hematoxylin purple nuclear counterstain. Personal Communi-cation, Tina Roush, LifeSpanBiosciences, Seattle, WA.
- Validation comment
- Immunohistochemistry